DDM-040 - ChemoGell - a thermosensitive injectable drug delivery vehicle for direct intratumoural delivery

• At: Copenhagen (Denmark) (2025)
• Type: Poster
• Poster code: DDM-040
• By: KELLY, Helena (RCSI University Of Medicine & Health Sciences, Ireland)
• Co-author(s): Prof Helena Kelly (RCSI University Of Medicine & Health Sciences, Dublin, Ireland)
  Dr. Christopher Simpson (RCSI University Of Medicine & Health Sciences, Dublin, Ireland)
  Prof L.J.A.C Hawinkels (Leiden University Medical Center, Leiden, Netherlands)
  Dr. Andrea Vallés-Martí (Leiden University Medical Center, Leiden, Netherlands)
  Dr Tushar Tomar (OncoLize LLC, Leiden, Netherlands)
  Mike de Leeuw (OncoLize LLC, Leiden, Netherlands)
  Li Zihao (RCSI University Of Medicine & Health Sciences, Dublin, Ireland)
  Dr Callum Herdman (RCSI University Of Medicine & Health Sciences, Dublin, Ireland)
  
• Abstract:

  Introduction
  Treatment for cancer is traditionally based around the three pillars of surgery, chemotherapy and radiation with immunotherapies playing an increasingly important role in certain cancers. Standard drug regimens are primarily delivered to the patient via intravenous (IV) injection, with the concomitant off-target toxic side effects..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login